JP2023531185A5 - - Google Patents
Info
- Publication number
- JP2023531185A5 JP2023531185A5 JP2022577477A JP2022577477A JP2023531185A5 JP 2023531185 A5 JP2023531185 A5 JP 2023531185A5 JP 2022577477 A JP2022577477 A JP 2022577477A JP 2022577477 A JP2022577477 A JP 2022577477A JP 2023531185 A5 JP2023531185 A5 JP 2023531185A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- sequence
- nos
- antibody fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063040894P | 2020-06-18 | 2020-06-18 | |
| US63/040,894 | 2020-06-18 | ||
| US202163166062P | 2021-03-25 | 2021-03-25 | |
| US63/166,062 | 2021-03-25 | ||
| PCT/US2021/037364 WO2021257525A1 (en) | 2020-06-18 | 2021-06-15 | Conditionally active anti-nectin-4 antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023531185A JP2023531185A (ja) | 2023-07-21 |
| JP2023531185A5 true JP2023531185A5 (cg-RX-API-DMAC7.html) | 2024-06-18 |
Family
ID=79268274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022577477A Pending JP2023531185A (ja) | 2020-06-18 | 2021-06-15 | 条件的に活性な抗ネクチン4抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230235054A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4168453A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023531185A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230038711A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115768798A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021293183A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3182395A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL298903A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022016192A (cg-RX-API-DMAC7.html) |
| TW (2) | TWI901704B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021257525A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114845740B (zh) | 2020-01-31 | 2026-06-02 | 先天制药公司 | 癌症的治疗 |
| JP2024501121A (ja) * | 2020-11-25 | 2024-01-11 | イナート・ファルマ・ソシエテ・アノニム | 癌の処置 |
| KR20240026496A (ko) * | 2021-06-29 | 2024-02-28 | 엘피스 바이오파마슈티컬즈 | 항-넥틴4 항체 및 이를 포함하는 다중특이적 단백질 복합체 |
| CN118696061A (zh) | 2022-01-12 | 2024-09-24 | 纳维再生科技股份有限公司 | Nectin细胞黏附分子4之特异性抗体及其用途 |
| CN116063498A (zh) * | 2022-04-27 | 2023-05-05 | 博际生物医药科技(杭州)有限公司 | 单域抗Nectin-4抗体 |
| CN117982672A (zh) * | 2022-07-14 | 2024-05-07 | 百奥泰生物制药股份有限公司 | 抗Nectin-4抗体药物偶联物及应用 |
| WO2024012536A1 (zh) * | 2022-07-14 | 2024-01-18 | 百奥泰生物制药股份有限公司 | 抗Nectin-4抗体、其抗体药物偶联物及应用 |
| EP4688851A1 (en) | 2023-03-27 | 2026-02-11 | LAVA Therapeutics N.V. | Nectin-4 binding agents and methods of use |
| EP4438624A1 (en) | 2023-03-27 | 2024-10-02 | LAVA Therapeutics N.V. | Antibodies that bind nectin-4 and gamma-delta t cell receptors |
| KR20260085122A (ko) * | 2023-09-29 | 2026-06-08 | 악티스 온콜로지, 인크. | 미니단백질, 접합체 및 이의 용도 |
| US20260226165A1 (en) * | 2024-12-17 | 2026-08-06 | Merck Sharp & Dohme Llc | Compositions and methods related to tumor activated molecules targeting nectin-4 and effector cell antigens |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3803790B2 (ja) * | 2003-02-17 | 2006-08-02 | 株式会社東北テクノアーチ | 新規なダイアボディ型二重特異性抗体 |
| US20110301056A1 (en) * | 2008-12-12 | 2011-12-08 | Oncotherapy Science, Inc. | Nectin-4 for target genes of cancer therapy and diagnosis |
| ES2874306T3 (es) * | 2010-09-29 | 2021-11-04 | Agensys Inc | Conjugados de anticuerpos y fármacos (CAF) que se unen a las proteínas 191P4D12 |
| EP3347048B1 (en) * | 2015-09-09 | 2020-04-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antibodies having specificity to nectin-4 and uses thereof |
| CA3003399A1 (en) * | 2015-11-02 | 2017-05-11 | Bioatla, Llc | Conditionally active polypeptides |
| MX2019002199A (es) * | 2016-08-31 | 2019-05-16 | Bioatla Llc | Polipeptidos condicionalmente activos y métodos para generarlos. |
| TWI870338B (zh) * | 2017-06-05 | 2025-01-21 | 美商艾澤西公司 | 粘附分子-4結合蛋白及其使用方法 |
| US12077583B2 (en) * | 2018-05-09 | 2024-09-03 | Nectin Therapeutics Ltd. | Antibodies specific to human NECTIN4 |
| CN112513081A (zh) * | 2018-06-14 | 2021-03-16 | 生物蛋白有限公司 | 多重特异性抗体构建体 |
-
2021
- 2021-06-15 IL IL298903A patent/IL298903A/en unknown
- 2021-06-15 EP EP21826366.3A patent/EP4168453A4/en active Pending
- 2021-06-15 CA CA3182395A patent/CA3182395A1/en active Pending
- 2021-06-15 JP JP2022577477A patent/JP2023531185A/ja active Pending
- 2021-06-15 US US18/002,064 patent/US20230235054A1/en active Pending
- 2021-06-15 MX MX2022016192A patent/MX2022016192A/es unknown
- 2021-06-15 CN CN202180043514.3A patent/CN115768798A/zh active Pending
- 2021-06-15 AU AU2021293183A patent/AU2021293183A1/en active Pending
- 2021-06-15 WO PCT/US2021/037364 patent/WO2021257525A1/en not_active Ceased
- 2021-06-15 KR KR1020237002055A patent/KR20230038711A/ko active Pending
- 2021-06-18 TW TW110122293A patent/TWI901704B/zh active
- 2021-06-18 TW TW114137356A patent/TW202604970A/zh unknown